“In-Depth In Silico Investigation Of Gitalin And Glaziovine As Possible VEGFR-2 Kinase Inhibitors For The Treatment Of Cancer”. Journal of Pharmaceutical Negative Results (December 31, 2022): 6523–6531. Accessed June 27, 2026. https://www.pnrjournal.com/index.php/home/article/view/10648.